Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps  Latest publication
4E2RCat
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Bedoradrine
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020
Peptide #2
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/11/2021
P5A-2F11
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
HB27
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/29/2021
P5A-1B9
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
TRS-1 PPMO
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/09/2020
5'END-1 PPMO
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/09/2020
5'END-2 PPMO
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/09/2020
U18666A
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/25/2020
TRS-2 PPMO
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/09/2020
P5A-2G7
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
ABP-700
Potential treatment - theoretical effect Experimental Antiviral Nov/06/2020
rbIFN-λ
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/03/2020
BC 007
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/31/2020
Propolis alcohol extract
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/07/2020
mNb6-tri
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/05/2020
CTC-445.2d
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/05/2020
CTC-445.2
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/05/2020
2-(3-(3-Chloro-4-fluorobenzoyl)-7-fluoro-4-hydroxy-1,1-dioxido-2H-benzo[e][1,2]thiazin-2-yl)-N-(4-(trifluoromethyl)phenyl)acetamide
Potential treatment - theoretical effect Experimental Antiviral Nov/04/2020